Skip to Main content Skip to Navigation
Journal articles

Advances in melanoma senescence and potential clinical application

Abstract : Normal cells possess a limited proliferative life span, after which they enter a state of irreversible growth arrest, called replicative senescence, which acts as a potent barrier against transformation. Transformed cells have escaped the process of replicative senescence and theoretically can not re-enter senescence. However, recent observations showed that transformed cells, and particularly the melanoma cells, can still undergo oncogene or stress-induced senescence. This senescence state is accompanied by many of the markers associated with replicative senescence, such as flattened shape, increased acidic β-galactosidase activity, characteristic changes in gene expression and growth arrest. Interestingly, in some cancers, senescence induction following chemotherapy has been correlated with a favorable patient outcome. In this review, we gathered recent results describing senescence-like phenotype induction in melanoma cells and discuss why senescence may also be exploited as a therapeutic strategy in melanoma.
Keywords : Senescence Melanoma
Complete list of metadatas

Cited literature [80 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02530650
Contributor : Bertolotto-Ballotti Bertolotto-Ballotti <>
Submitted on : Tuesday, April 7, 2020 - 2:17:46 PM
Last modification on : Tuesday, May 26, 2020 - 6:50:32 PM

File

Bertolotto PCMR 2011.pdf
Files produced by the author(s)

Identifiers

Collections

Citation

Sandy Giuliano, Mickaël Ohanna, Robert Ballotti, Corine Bertolotto. Advances in melanoma senescence and potential clinical application. Pigment Cell & melanoma research, Blackwell Munksgaard, 2011, 24 (2), pp.295-308. ⟨10.1111/j.1755-148X.2010.00820.x⟩. ⟨inserm-02530650⟩

Share

Metrics

Record views

22

Files downloads

26